Sarah Diggelmann

565 total citations
3 papers, 33 citations indexed

About

Sarah Diggelmann is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Sarah Diggelmann has authored 3 papers receiving a total of 33 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Oncology, 2 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Immunology. Recurrent topics in Sarah Diggelmann's work include Biosimilars and Bioanalytical Methods (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and CAR-T cell therapy research (2 papers). Sarah Diggelmann is often cited by papers focused on Biosimilars and Bioanalytical Methods (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and CAR-T cell therapy research (2 papers). Sarah Diggelmann collaborates with scholars based in Switzerland and Germany. Sarah Diggelmann's co-authors include Marina Bacac, Sylvia Herter, Patrick Caspers, Hans H. Locher, Christina Claus, Christian Klein, Daniel Bur, Daniel Ritz, Pablo Umaña and Tina Weinzierl and has published in prestigious journals such as Blood, Antimicrobial Agents and Chemotherapy and Molecular Cancer Therapeutics.

In The Last Decade

Sarah Diggelmann

3 papers receiving 33 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sarah Diggelmann Switzerland	3	17	12	10	9	8	3	33
Allan Feng United States	2	10 0.6×	6 0.5×	36 3.6×	9 1.0×	7 0.9×	3	51
Juan J Lence Cuba	5	22 1.3×	3 0.3×	7 0.7×	11 1.2×	5 0.6×	9	45
Joe Fenn United Kingdom	4	11 0.6×	13 1.1×	33 3.3×	27 3.0×	11 1.4×	7	57
Teruaki Murakami Japan	5	7 0.4×	3 0.3×	14 1.4×	4 0.4×	10 1.3×	7	43
Vipheaviny Chea United States	2	10 0.6×	9 0.8×	15 1.5×	29 3.2×	3 0.4×	2	36
Suzanna Rachimi United States	2	10 0.6×	9 0.8×	15 1.5×	29 3.2×	3 0.4×	5	37
Leslie Y. T. Leung Canada	6	8 0.5×	15 1.3×	38 3.8×	16 1.8×	8 1.0×	7	60
Ahmed S. Fahad United States	4	8 0.5×	13 1.1×	20 2.0×	19 2.1×	2 0.3×	15	37
Rebekka Niederer Switzerland	3	27 1.6×	4 0.3×	17 1.7×	8 0.9×	2 0.3×	6	44
Charbel Merheb France	4	22 1.3×	15 1.3×	3 0.3×	9 1.0×		5	45

Countries citing papers authored by Sarah Diggelmann

Since Specialization

Citations

This map shows the geographic impact of Sarah Diggelmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Diggelmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Diggelmann more than expected).

Fields of papers citing papers by Sarah Diggelmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Diggelmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Diggelmann. The network helps show where Sarah Diggelmann may publish in the future.

Co-authorship network of co-authors of Sarah Diggelmann

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Diggelmann. A scholar is included among the top collaborators of Sarah Diggelmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Diggelmann. Sarah Diggelmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

3 of 3 papers shown

1.

Weinzierl, Tina, Nicolas Frances, Sylvia Herter, et al.. (2020). Predicting Tumor Killing and T-Cell Activation by T-Cell Bispecific Antibodies as a Function of Target Expression: Combining In Vitro Experiments with Systems Modeling. Molecular Cancer Therapeutics. 20(2). 357–366. 16 indexed citations

2.

Herter, Sylvia, Johannes Sam, Claudia Ferrara, et al.. (2020). RG6076 (CD19-4-1BBL): CD19-Targeted 4-1BB Ligand Combination with Glofitamab As an Off-the-Shelf, Enhanced T-Cell Redirection Therapy for B-Cell Malignancies. Blood. 136(Supplement 1). 40–40. 8 indexed citations

3.

Caspers, Patrick, Hans H. Locher, Sarah Diggelmann, et al.. (2017). Different Resistance Mechanisms for Cadazolid and Linezolid in Clostridium difficile Found by Whole-Genome Sequencing Analysis. Antimicrobial Agents and Chemotherapy. 61(8). 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact